Pathogenese der Psoriasis vulgaris
Psoriasis is an inflammatory T cell-mediated autoimmune disease of skin and joints that affects 2-4 % of the adult population and 0.1-1 % of children. Genetic susceptibility, environmental triggering factors, and innate immune processes initiate psoriasis pathogenesis that results in an adaptive aut...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | German |
| Published: |
31. Mai 2016
|
| In: |
Der Hautarzt
Year: 2016, Volume: 67, Issue: 6, Pages: 422-431 |
| ISSN: | 1432-1173 |
| DOI: | 10.1007/s00105-016-3800-8 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1007/s00105-016-3800-8
|
| Author Notes: | K. Schäkel, M.P. Schön, K. Ghoreschi |
| Summary: | Psoriasis is an inflammatory T cell-mediated autoimmune disease of skin and joints that affects 2-4 % of the adult population and 0.1-1 % of children. Genetic susceptibility, environmental triggering factors, and innate immune processes initiate psoriasis pathogenesis that results in an adaptive autoreactive response. The T cell response is orchestrated by CD 8+ T cells in the epidermis and by CD 4+ T cells in the dermis that predominantly produce interleukin-17 (IL‑17). Research of the past 15 years unraveled cellular and molecular mechanisms as well as cytokines like TNF-α or IL‑23 that contribute to psoriatic inflammation. This knowledge has been translated into clinical practice and a number of antipsoriatic small molecules and immunobiologics are now available. Here, we discuss the current principles of psoriasis pathogenesis in the context of modern therapies. |
|---|---|
| Item Description: | Gesehen am 08.08.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1173 |
| DOI: | 10.1007/s00105-016-3800-8 |